IPP Bureau
Budget 2024-25: Industry expects push for reforms, R&D and fiscal incentives
By IPP Bureau - July 22, 2024
Finance Minister Nirmala Sitharaman is set to present the full budget for the current financial year on July 23
Singhi Advisors facilitates acquisition of 85% stake of GMP Technical Solutions by Japanese Shinryo Corporation
By IPP Bureau - July 22, 2024
This transaction is the third acquisition by three different Japanese players in this segment
New data for Roche’s Susvimo demonstrates sustained efficacy in two serious diabetic eye conditions
By IPP Bureau - July 22, 2024
Susvimo is a unique therapeutic approach that provides continuous delivery of medicine to the eye through a refillable implant
Lupin and Huons Sign agreement for commercialization of cyclosporine ophthalmic nanoemulsion in Mexico
By IPP Bureau - July 22, 2024
Cyclosporine Ophthalmic Nanoemulsion is a preservative-free Nanoemulsion that has been approved in South Korea, Peru and several countries in the Middle East for treatment of dry eye syndrome
Lupin’s partner ForDoz receives USFDA approval for doxorubicin hydrochloride liposome injection
By IPP Bureau - July 22, 2024
Doxorubicin Hydrochloride Liposome Injection (RLD Doxil) had estimated annual sales of USD 42 million in the U.S. (IQVIA MAT May 2024)
Elucid appoints Kelly Huang as CEO
By IPP Bureau - July 22, 2024
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
Zydus signs patent licensing agreement with Takeda for 'VaultA’ in India
By IPP Bureau - July 19, 2024
The pooled prevalence of GERD in the Indian population is 15.6 %
Kwality Pharmaceuticals receives DIGIMED approval for generic, injectable and OSD
By IPP Bureau - July 19, 2024
Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration
Vimta Labs posts Q1 FY25consolidated PAT at Rs. 12.28 Cr
By IPP Bureau - July 19, 2024
Vimta Labs has reported total income of Rs. 82.44 crores during the period ended June 30, 2024
Unichem gets 5 observations from USFDA for Goa formulation facility
By IPP Bureau - July 17, 2024
The inspection closed with five observations which were more of procedural changes with none of these related to data integrity
Lupin divests US commercial women's health specialty business to Evofem
By IPP Bureau - July 17, 2024
Lupin can receive a potential total consideration of up to USD 84 million based on future contingent milestones
Mankind Pharma signs agreement with Takeda to commercialize Vonoprazan in India
By IPP Bureau - July 17, 2024
Vonoprazan is a potassium-competitive acid blocker (P-CAB) used for the treatment of acid-related disorders
Avallano releases AI-driven ProtocolCopilot
By IPP Bureau - July 17, 2024
ProtocolCopilot leverages advanced artificial intelligence to streamline the process of understanding and adhering to clinical research protocols
Medix Biochemica appoints former Thermo Fisher Scientific Lonnie Shoff to its Board of Directors
By IPP Bureau - July 16, 2024
Shoff brings over 30 years of international experience in in vitro diagnostics, healthcare distribution and veterinary diagnostics
